Company Filing History:
Years Active: 2014-2017
Title: Chetan Kanaiyalal Raval: Innovator in Pharmaceutical Patents
Introduction
Chetan Kanaiyalal Raval is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel polymorphic forms of drugs. With a total of 2 patents to his name, Raval's work is recognized for its innovation and practical applications.
Latest Patents
Raval's latest patents focus on the polymorphic forms of Perindopril (L)-Arginine. The first patent describes novel and stable polymorphic forms designated as Form γ and an amorphous form, along with processes for their preparation. This invention emphasizes the greater stability of Form γ to heat and humidity, making it suitable for large-scale production through an efficient, economic, and reproducible process. The second patent reiterates the same innovative aspects, highlighting the importance of stability in pharmaceutical formulations.
Career Highlights
Chetan Raval is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create effective pharmaceutical solutions. His contributions have been instrumental in advancing the company's product offerings.
Collaborations
Raval has collaborated with notable colleagues, including Ramakoteswara Rao Jetti and Aggi Ramireddy Bommareddy. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Chetan Kanaiyalal Raval is a distinguished inventor whose work in pharmaceutical patents has made a lasting impact. His innovative approaches to drug formulation and stability continue to influence the industry positively.